Profound Medical (NASDAQ:PROF – Get Free Report) and Assure (NASDAQ:IONM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.
Institutional & Insider Ownership
47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a summary of current recommendations for Profound Medical and Assure, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Profound Medical | 0 | 0 | 3 | 1 | 3.25 |
| Assure | 0 | 0 | 0 | 0 | 0.00 |
Volatility and Risk
Profound Medical has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Comparatively, Assure has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500.
Earnings & Valuation
This table compares Profound Medical and Assure”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Profound Medical | $8.98 million | 23.33 | -$28.57 million | ($1.34) | -5.21 |
| Assure | $149,000.00 | 0.94 | -$26.08 million | N/A | N/A |
Assure has lower revenue, but higher earnings than Profound Medical.
Profitability
This table compares Profound Medical and Assure’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Profound Medical | -349.41% | -85.22% | -64.87% |
| Assure | -25,178.32% | N/A | -249.78% |
Summary
Profound Medical beats Assure on 9 of the 13 factors compared between the two stocks.
About Profound Medical
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
About Assure
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.
